每經AI快訊，香雪制藥(yao)（SZ 300147，收盤(pan)價：3.98元(yuan)）5月17日晚(wan)間發布公(gong)(gong)(gong)(gong)(gong)告(gao)稱，公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)董(dong)事(shi)(shi)會于近(jin)日收到(dao)董(dong)事(shi)(shi)陳文進(jin)先(xian)(xian)生的辭呈，其(qi)申請辭去(qu)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)第九屆董(dong)事(shi)(shi)會非獨立董(dong)事(shi)(shi)職務(wu)(wu)和薪酬(chou)與考核(he)委員(yuan)會委員(yuan)職務(wu)(wu)，原定任(ren)(ren)(ren)期至公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)第九屆董(dong)事(shi)(shi)會屆滿之(zhi)日止。根據工作需要(yao)，牛曉燕女士不再(zai)擔(dan)任(ren)(ren)(ren)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)財務(wu)(wu)總監職務(wu)(wu)，離任(ren)(ren)(ren)后(hou)將(jiang)在(zai)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)擔(dan)任(ren)(ren)(ren)其(qi)他職務(wu)(wu)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)同(tong)意(yi)聘任(ren)(ren)(ren)朱維彬(bin)先(xian)(xian)生為公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)財務(wu)(wu)總監。公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)第九屆董(dong)事(shi)(shi)會第十九次會議，同(tong)意(yi)聘任(ren)(ren)(ren)林振(zhen)邦先(xian)(xian)生為公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)證券事(shi)(shi)務(wu)(wu)代表。

2023年1至12月份，香雪(xue)制藥(yao)的(de)營業收(shou)入(ru)構成(cheng)為：醫(yi)藥(yao)制造(zao)占比(bi)(bi)(bi)35.89%，中藥(yao)材占比(bi)(bi)(bi)32.39%，醫(yi)藥(yao)流通占比(bi)(bi)(bi)15.67%，其它占比(bi)(bi)(bi)15.29%，醫(yi)療器械占比(bi)(bi)(bi)0.76%。

截至發稿，香雪制藥市值為26億元。

道(dao)達號（daoda1997）“個股趨勢(shi)”提醒：
1. 香雪制藥近30日內北向資金持股量未發生變化；
2. 近30日內無機構對香雪制藥進行調研；
3. 香雪制藥上一次發布(bu)人事變(bian)(bian)動公(gong)告是2024年04月(yue)30日，香雪制藥近一年共(gong)發布(bu)2次人事變(bian)(bian)動公(gong)告。

每(mei)經頭條（nbdtoutiao）——

(記者 蔡鼎)

免責聲(sheng)明(ming)：本文內容與數(shu)據僅供(gong)參考(kao)，不構成投(tou)資建議，使用前請核實。據此操作，風險自擔。